Muller AE - Search Results

1

Pharmacodynamics of Temocillin in Neutropenic Murine Infection Models.

Muller AE, Raaphorst M, van der Meijden A, de Winter BCM, Meletiadis J, van den Berg S. Muller AE, et al. Antimicrob Agents Chemother. 2023 Feb 16;67(2):e0143322. doi: 10.1128/aac.01433-22. Epub 2023 Jan 24. Antimicrob Agents Chemother. 2023. PMID: 36692307 Free PMC article.

2

Exposure to ceftobiprole is associated with microbiological eradication and clinical cure in patients with nosocomial pneumonia.

Muller AE, Punt N, Mouton JW. Muller AE, et al. Antimicrob Agents Chemother. 2014 May;58(5):2512-9. doi: 10.1128/AAC.02611-13. Epub 2014 Feb 10. Antimicrob Agents Chemother. 2014. PMID: 24514085 Free PMC article. Clinical Trial.

3

Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration.

Laterre PF, Wittebole X, Van de Velde S, Muller AE, Mouton JW, Carryn S, Tulkens PM, Dugernier T. Laterre PF, et al. Among authors: muller ae. J Antimicrob Chemother. 2015 Mar;70(3):891-8. doi: 10.1093/jac/dku465. Epub 2014 Nov 27. J Antimicrob Chemother. 2015. PMID: 25433006 Clinical Trial.

4

Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients.

Abdulla A, Rogouti O, Hunfeld NGM, Endeman H, Dijkstra A, van Gelder T, Muller AE, de Winter BCM, Koch BCP. Abdulla A, et al. Among authors: muller ae. Eur J Clin Pharmacol. 2020 Jul;76(7):957-967. doi: 10.1007/s00228-020-02873-5. Epub 2020 Apr 19. Eur J Clin Pharmacol. 2020. PMID: 32307575 Free PMC article. Clinical Trial.

5

Therapeutic Drug Monitoring of Antibiotics in Critically Ill Patients: Current Practice and Future Perspectives With a Focus on Clinical Outcome.

Koch BCP, Muller AE, Hunfeld NGM, de Winter BCM, Ewoldt TMJ, Abdulla A, Endeman H. Koch BCP, et al. Among authors: muller ae. Ther Drug Monit. 2022 Feb 1;44(1):11-18. doi: 10.1097/FTD.0000000000000942. Ther Drug Monit. 2022. PMID: 34772892 Review.

6

Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients.

de Velde F, de Winter BCM, Neely MN, Strojil J, Yamada WM, Harbarth S, Huttner A, van Gelder T, Koch BCP, Muller AE, On Behalf Of The Combacte-Net Consortium. de Velde F, et al. Among authors: muller ae. Pharmaceutics. 2021 Dec 16;13(12):2170. doi: 10.3390/pharmaceutics13122170. Pharmaceutics. 2021. PMID: 34959451 Free PMC article.

7

Dose optimization of cefotaxime as pre-emptive treatment in critically ill adult patients: A population pharmacokinetic study.

Roelofsen EE, Abdulla A, Muller AE, Endeman H, Gommers D, Dijkstra A, Hunfeld NGM, de Winter BCM, Koch BCP. Roelofsen EE, et al. Among authors: muller ae. Br J Clin Pharmacol. 2023 Feb;89(2):705-713. doi: 10.1111/bcp.15487. Epub 2022 Sep 27. Br J Clin Pharmacol. 2023. PMID: 35942921 Free PMC article.

8

The mysteries of target site concentrations of antibiotics in bone and joint infections: what is known? A narrative review.

Koch BCP, Zhao Q, Oosterhoff M, van Oldenrijk J, Abdulla A, de Winter BCM, Bos K, Muller AE. Koch BCP, et al. Among authors: muller ae. Expert Opin Drug Metab Toxicol. 2022 Sep;18(9):587-600. doi: 10.1080/17425255.2022.2117607. Epub 2022 Sep 4. Expert Opin Drug Metab Toxicol. 2022. PMID: 36008360 Review.

9

Pharmacodynamics of Flucloxacillin in a Neutropenic Murine Thigh Infection Model: A Piece of the Puzzle towards Evidence-Based Dosing.

Roelofsen EE, de Winter BCM, van der Spek H, Snijders S, Koch BCP, van den Berg S, Muller AE. Roelofsen EE, et al. Among authors: muller ae. Antibiotics (Basel). 2022 Aug 3;11(8):1049. doi: 10.3390/antibiotics11081049. Antibiotics (Basel). 2022. PMID: 36009918 Free PMC article.

10

Binding of temocillin to plasma proteins in vitro and in vivo: the importance of plasma protein levels in different populations and of co-medications.

Ngougni Pokem P, Matzneller P, Vervaeke S, Wittebole X, Goeman L, Coessens M, Cottone E, Capron A, Wulkersdorfer B, Wallemacq P, Mouton JW, Muller AE, Zeitlinger M, Laterre PF, Tulkens PM, Van Bambeke F. Ngougni Pokem P, et al. Among authors: muller ae. J Antimicrob Chemother. 2022 Sep 30;77(10):2742-2753. doi: 10.1093/jac/dkac286. J Antimicrob Chemother. 2022. PMID: 36018077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page